# TOKIWA-Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tokiwa-bio

- Industry: Biotechnology
- Headquarters: Tsukuba, Japan
- Website: https://tokiwa-bio.com/
- Total disclosed funding: $5.5M
- Latest round: Series B (Oct 20, 2025)
- Investors on record: 8

## About

Founded in 2014, based in Ibaraki, Japan. TOKIWA-Bio Inc. conducts research and develops a unique gene expression system "Stealth RNA vector (SRV)".
They also develop regenerative medicine and provide support for drug discovery.

## Funding rounds

- Series B, Oct 20, 2025, $2.6M — Joyo Capital Partners, Rohto Pharmaceutical, TOHOKU University Venture Partners, Kyoto University Innovation Capital
- Series A, Nov 15, 2017, $2.9M — Nippon Venture Capital, Fujifilm Holdings Corporation, Japan Science and Technology Agency, Anicom Capital

## Investors

- Nippon Venture Capital (https://capitalatlas.ai/funds/nippon-venture-capital) — Series A
- Fujifilm Holdings Corporation — Series A
- Japan Science and Technology Agency — Series A
- Anicom Capital — Series A
- Joyo Capital Partners (https://capitalatlas.ai/funds/joyo-capital-partners) — Series B
- Rohto Pharmaceutical — Series B
- TOHOKU University Venture Partners (https://capitalatlas.ai/funds/tohoku-university-venture-partners) — Series B
- Kyoto University Innovation Capital (https://capitalatlas.ai/funds/kyoto-university-innovation-capital) — Series B